IBM Retirement Fund’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
1WCM
FCMI
IBM Retirement Fund's TXG Position: Q1 2022 in Review
IBM Retirement Fund sold out of 10x Genomics (TXG) in Q1 2022, closing a stake of 1,393 shares — an estimated $208K sold.
IBM Retirement Fund first reported a position in TXG in Q3 2020 and held it in 6 quarters. The position peaked at $464K in Q2 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.
- IBM Retirement Fund reported no remaining 10x Genomics position as of Q1 2022 after selling out during the quarter.
- IBM Retirement Fund sold 1,393 10x Genomics shares in Q1 2022, an estimated $208K.
- IBM Retirement Fund first reported a position in 10x Genomics in Q3 2020 and held it in 6 quarters.
- IBM Retirement Fund's 10x Genomics position peaked at $464K in Q2 2021.
- 314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.
Based on IBM Retirement Fund's 13F filing for Q1 2022, filed 14 Apr 2022.